According to a new report,“Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 – 2024”, published by Grand View Research, Inc., the global continuous glucose monitoring (CGM) devices market size is expected to reach USD 1.01 billion by 2024. The market is estimated to register a CAGR of 13.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.
Key Takeaways from the report:
Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
Transmitters and receivers was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
Insulin pumps are anticipated to witness the highest CAGR during the forecast period due to their ability to maintain optimal blood glucose levels
Asia Pacific is the leading regional market, with Japan, China, and India on the forefront
North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain
Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.
Browse More Reports in Medical Devices Industry:
These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of CGM devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward market growth.
Grand View Research has segmented the global continuous glucose monitoring (CGM) devices market on the basis of component, end use, and region:
Continuous Glucose Monitoring Devices Component Outlook (Revenue, USD Million, 2013 – 2024)
Transmitters & Receivers
Sensors
Insulin Pumps
Continuous Glucose Monitoring Devices End-use Outlook (Revenue, USD Million, 2013 – 2024)
Hospitals
Homecare Settings
Others
Continuous Glucose Monitoring Devices Regional Outlook (Revenue, USD Million, 2013 – 2024)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: SwitzerlandWebsite: www.grandviewresearch.com/industry-analysis/continuous-glucose-monitoring-market